Paul Webb
25Patents
6h-index
30Co-inventors
69Inventor score
Filing activity: Oct 18, 1976 → Jan 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4092722A | Fluid catalytic cracking with automatic temperature control | Emerging Cross-Sectional Technologies | 15 | Expired |
| US9125804B2 | Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose | Emerging Cross-Sectional Technologies | 14 | Active |
| US5723291A | Methods for screening compounds for estrogenic activity | Physics | 10 | Expired |
| US10561604B2 | Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose | Emerging Cross-Sectional Technologies | 10 | Active |
| US8507480B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 7 | Active |
| US9757329B2 | Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose | Emerging Cross-Sectional Technologies | 7 | Active |
| US7705027B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 6 | Expired |
| US7790680B2 | Stable pharmaceutical composition containing factor VIII | Human Necessities | 4 | Expired |
| US5091570A | Method for preparation of dialkyl tellurium and dialkyl selenium | Chemistry; Metallurgy | 4 | Expired |
| US7302347B2 | Method for creating specific, high affinity nuclear receptor pharmaceuticals | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8450310B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 4 | Active |
| US6884577B2 | Methods for screening compounds for estrogenic activity | Physics | 2 | Expired |
| US9718793B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 2 | Active |
| US8551371B2 | Method and composition | Textiles; Paper | 2 | Active |
| US6156723A | Compositions comprising inhibitors of estrogen response | Physics | 1 | Expired |
| US8916591B2 | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity | Chemistry; Metallurgy | 1 | Active |
| US6117638A | Methods to screen for transcription factor-coactivator interactions | Chemistry; Metallurgy | 1 | Expired |
| US10413550B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 1 | Active |
| US11534394B2 | Pharmaceutical composition containing botulinum neurotoxin | Emerging Cross-Sectional Technologies | 0 | Active |
| US8853106B2 | Phosphorus-contaning flame-retardant compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US5117021A | Method for purification of tellurium and selenium alkyls | Chemistry; Metallurgy | 0 | Expired |
| US10696652B2 | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity | Chemistry; Metallurgy | 0 | Active |
| US9890100B2 | Continuous process for the production of low molecular weight polyethers with a DMC catalyst | Chemistry; Metallurgy | 0 | Active |
| US11234987B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 0 | Active |
| US9604975B2 | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.